Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma

ClinicalTrials.gov ID: NCT00328887

Public ClinicalTrials.gov record NCT00328887. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 20, 2026, 7:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I, Initial Safety/Toxicity Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdCUCD40L) to Patients With Stage III or IV Esophageal Carcinoma

Study identification

NCT ID: NCT00328887
Recruitment status: Withdrawn
Study type: Interventional
Phase: Phase 1
Lead sponsor: Weill Medical College of Cornell University; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Esophageal Neoplasms

Interventions

CD40 Gene Transfer Genetic

Genetic

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 31, 2004
Primary completion: Jun 30, 2010
Completion: Jun 30, 2010
Last update posted: May 2, 2016

2004 – 2010

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
The Valley Hospital	Ridgewood	New Jersey	07450	—
Weill Medical College of Cornell University	New York	New York	10021	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00328887, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 2, 2016 · Synced Jul 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00328887 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →